- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Abraxis BioScience, Inc. (NASDAQ: ABBI), an integrated, global biopharmaceutical company, today announced that Patrick Soon-Shiong, M.D., founder, chairman of the board and chief executive officer of the company, was among this year's 100 recipients of the prestigious Ellis Island Medal of Honor. Honorees this year included Her Excellency Sheikha Haya Rashed Al Khalifa (President - General Assembly, United Nations), Denis A. Cortese, M.D. (President and Chief Executive Officer - Mayo Clinic), Hon. Chuck Hagel (U. S. Senator), Rep. Tom Lantos ((U.S. Congressman) and Antonio M. Perez (Chairman and Chief Executive Officer - Eastman Kodak Company). The award presentation took place at Ellis Island on May 12, 2007 and the ceremony concluded with a fireworks display at the Statue of Liberty.
Dr. Soon-Shiong, who is of Chinese heritage and a native of South Africa, is a noted research scientist, physician and surgeon, and was awarded this honor for his efforts in scientific innovation. He has devoted his career to developing next-generation technologies to enhance the medical care of patients with life-threatening diseases, including cancer, diabetes and heart disease. Dr. Soon-Shiong performed the world's first encapsulated islet transplant in a diabetic patient, developed the nanoparticle albumin bound (nab™) technology platform, is a co-inventor of over 50 issued U.S. and foreign patents and has published more than 100 scientific papers.
As part of his commitment to bringing about evolutionary change to the practice of medicine and addressing the serious health care issues facing the country, Dr. Soon-Shiong and his family recently donated $35 million to the Saint John's Health Center. The donation was designed to complete the building of a world class inpatient life science center, and to begin development of a new Center for Translational Sciences.
The Ellis Island Medal of Honor, sponsored by the National Ethnic Coalition of Organizations, is presented annually to Americans who have maintained strong ties to their ancestry and furthered the growth of ethnic America. Previous honorees have been outstanding Americans who have worked in government, healthcare, industry, education, sports and entertainment. Recipients have included six United States Presidents, General Norman Schwarzkopf, Rudy Guiliani, Jay Leno, Yogi Berra, Muhammad Ali and Walter Cronkite.
About Abraxis BioScience, Inc.
Abraxis BioScience, Inc. is an integrated global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures and markets one of the broadest portfolios of injectable products and leverages revolutionary technology such as its nab™ platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE®, was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on the Nasdaq Global Market under the symbol ABBI. For more information about the company and its products, please visit http://www.abraxisbio.com .
For more information, please click here
Abraxis BioScience, Inc.
Investors and Media:
Copyright © Business Wire 2007If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Cooling graphene-based film close to pilot-scale production April 30th, 2016
Personal cooling units on the horizon April 29th, 2016
Exploring phosphorene, a promising new material April 29th, 2016
Correction: Solar fuels: Protective layer for the 'artificial leaf' March 22nd, 2016
Brookhaven's Oleg Gang Named a Battelle 'Inventor of the Year': Recognized for work using DNA to guide and regulate the self-assembly of nanoparticles into clusters and arrays with controllable properties April 25th, 2016